Amber Kelley, PA
Physician Assistant · Mooresville, INNPI 1982656674
Payments from drug & device makers
Across 28 payments — averaging $18.11 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novartis$131
- Pfizer$62
- Johnson & Johnson$58
- Amgen$57
- UCB, Inc.$35
- Regeneron Healthcare Solutions, Inc.$34
- plus $130 from 6 others
What the payments were for
- Food & beverage$507100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novartis | 6 | $131 |
| Pfizer | 3 | $62 |
| Johnson & Johnson | 4 | $58 |
| Amgen | 3 | $57 |
| UCB, Inc. | 2 | $35 |
| Regeneron Healthcare Solutions, Inc. | 2 | $34 |
| Galderma Laboratories, L.p. | 2 | $32 |
| Incyte Corporation | 2 | $30 |
| Sun Pharmaceutical Industries Inc. | 1 | $27 |
| Dermavant Sciences, Inc. | 1 | $15 |
| Arcutis Biotherapeutics, Inc. | 1 | $15 |
| Lilly USA, LLC | 1 | $12 |
How this compares
$507 in reported general payments places this provider in the 65th percentile of 1,955 physician assistant providers in Indiana.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Skyrizi PenRisankizumab-Rzaa | 12 | $253,662 |
| RinvoqUpadacitinib | 12 | $79,490 |
| CiclopiroxCiclopirox Olamine | 118 | $2,840 |
| Clobetasol Propionate | 66 | $2,177 |
| Fluorouracil | 18 | $1,305 |
| Metronidazole | 24 | $1,243 |
| Ketoconazole | 82 | $912 |
| Triamcinolone Acetonide | 73 | $818 |
| ValacyclovirValacyclovir Hcl | 14 | $775 |
| Desonide | 17 | $768 |
| Clindamycin Phosphate | 16 | $713 |
| Doxycycline Hyclate | 28 | $276 |
| Mupirocin | 18 | $157 |
Paid to pharmacies, not to this prescriber.
Other physician assistant in Mooresville
- Kristen GumpfCarmel$142K
- Andrew NordIndianapolis$47K
- Qun Ming ZhangIndianapolis$28K
- Lauren HoweMunster$28K
- A FergusonFort Wayne$22K
- Jacquelyn BeemerFort Wayne$21K
- Lindsay YoderIndianapolis$21K
- Eryn GormanClinton$18K
- Audrey HewittBloomington$17K
- Mackenzie LawsonIndianapolis$15K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.